Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 Apr;31(4):871-9.
doi: 10.1007/s10554-015-0618-x. Epub 2015 Feb 17.

Predicting pulmonary hypertension with standard computed tomography pulmonary angiography

Onno A Spruijt  1 , Harm-Jan Bogaard, Martijn W Heijmans, Rutger J Lely, Mariëlle C van de Veerdonk, Frances S de Man, Nico Westerhof, Anton Vonk-Noordegraaf
Affiliations
Comparative Study

Predicting pulmonary hypertension with standard computed tomography pulmonary angiography

Onno A Spruijt et al. Int J Cardiovasc Imaging. 2015 Apr.

Abstract

The most common feature of pulmonary hypertension (PH) on computed tomography pulmonary angiography (CTPA) is an increased diameter-ratio of the pulmonary artery to the ascending aorta (PA/AAAX). The aim of this study was to investigate whether combining PA/AAAX measurements with ventricular measurements improves the predictive value of CTPA for precapillary PH. Three predicting models were analysed using baseline CTPA scans of 51 treatment naïve precapillary PH patients and 25 non-PH controls: model 1: PA/AAAX only; model 2: PA/AAAX combined with the ratio of the right ventricular and left ventricular diameter measured on the axial view (RV/LVAX); model 3: PA/AAAX combined with the RV/LV-ratio measured on a four chamber view (RV/LV4CH). Prediction models were compared using multivariable binary logistic regression, ROC analyses and decision curve analyses (DCA). Multivariable binary logistic regression showed an improvement of the predictive value of model 2 (-2LL = 26.48) and 3 (-2LL = 21.03) compared to model 1 (-2LL = 21.03). ROC analyses showed significantly higher AUCs of model 2 and 3 compared to model 1 (p = 0.011 and p = 0.007, respectively). DCA showed an increased clinical benefit of model 2 and 3 compared to model 1. The predictive value of model 2 and 3 were almost equal. We found an optimal cut-off value for the RV/LV-ratio for predicting precapillary PH of RV/LV ≥ 1.20. The predictive value of CTPA for precapillary PH improves when ventricular and pulmonary artery measurements are combined. A PA/AAAX ≥ 1 or a RV/LVAX ≥ 1.20 needs further diagnostic evaluation to rule out or confirm the diagnosis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
CTPA parameters a Pulmonary artery (PA) and ascending aorta (AA) ratio (PA/AAAX) on an axial view at the level of the bifurcation of the pulmonary trunk. b Right ventricle (RV) and left ventricle (LV) ratio (RV/LVAX) on an axial view. The RV diameter is measured perpendicular to the long axis of the heart. The LV diameter is not measured in this image, since the maximum diameter of the LV is not necessarily on the same image c RV/LV4CH on a four chamber (4CH) view
Fig. 2
Fig. 2
Area Under the Curve (AUC) of the three different models. Blue line = model 1, Green line = model 2, Red line = model 3
Fig. 3
Fig. 3
Decision curve analysis. Decision curve analysis of the three models to predict the presence of precapillary PH. On the right an expended view of the curves at low threshold probabilities, ranging from 0 to 20 %
See this image and copyright information in PMC

References

    1. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009;34:1219–12163. doi: 10.1183/09031936.00139009. - DOI - PubMed
    1. Vonk Noordegraaf A, Galie N. The role of the right ventricle in pulmonary arterial hypertension. Eur Respir Rev. 2011;20:243–253. doi: 10.1183/09059180.00006511. - DOI - PMC - PubMed
    1. Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JS, Howard LS, Pepke-Zaba J, Sheares KK, Corris PA, Fisher AJ, Lordan JL, Gaine S, Coghlan JG, Wort SJ, Gatzoulis MA, Peacock AJ. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med. 2012;186:790–796. doi: 10.1164/rccm.201203-0383OC. - DOI - PubMed
    1. Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon MD. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010;137:376–387. doi: 10.1378/chest.09-1140. - DOI - PubMed
    1. Strange G, Gabbay E, Kermeen F, Williams T, Carrington M, Stewart S, Keogh A. Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension: the delay study. Pulm Circ. 2013;3:89–94. doi: 10.4103/2045-8932.109919. - DOI - PMC - PubMed

Publication types

LinkOut - more resources